These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23858974)

  • 1. Analysis of beta amyloid peptides employing the small probe molecules.
    Hong HB; Nam IH; Sohn SW; Song KB
    J Biomed Nanotechnol; 2013 Jun; 9(6):1088-91. PubMed ID: 23858974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of amyloid-β fibrils using the DNA-intercalating dye YOYO-1: Binding mode and fibril formation kinetics.
    Lindberg DJ; Esbjörner EK
    Biochem Biophys Res Commun; 2016 Jan; 469(2):313-8. PubMed ID: 26612254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies.
    Irwin JA; Edward Wong H; Kwon I
    Anal Biochem; 2015 Feb; 470():61-70. PubMed ID: 25449301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures.
    Reinke AA; Ung PM; Quintero JJ; Carlson HA; Gestwicki JE
    J Am Chem Soc; 2010 Dec; 132(50):17655-7. PubMed ID: 21105683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
    Lu X; Brickson CR; Murphy RM
    ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of oligomeric and protofibrillar Aβ amyloid pair structures considering F20L mutation effects using molecular dynamics simulations.
    Lee M; Chang HJ; Baek I; Na S
    Proteins; 2017 Apr; 85(4):580-592. PubMed ID: 28019690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Molecular Interactions of Aβ1-42 with N-Terminal Truncated Beta Amyloids by NMR.
    Tomaselli S; Pagano K; D'Arrigo C; Molinari H; Ragona L
    ACS Chem Neurosci; 2017 Apr; 8(4):759-765. PubMed ID: 28135060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
    Jin Y; Sun Y; Lei J; Wei G
    Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study.
    Mehrazma B; Robinson M; Opare SKA; Petoyan A; Lou J; Hane FT; Rauk A; Leonenko Z
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt B):1707-1718. PubMed ID: 28844735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
    Olofsson A; Lindhagen-Persson M; Sauer-Eriksson AE; Ohman A
    Biochem J; 2007 May; 404(1):63-70. PubMed ID: 17280549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of mutations and modifications of amino acid residues on zinc-induced interaction of the metal-binding domain of β-amyloid with DNA].
    Khmeleva SA; Mezentsev YV; Kozin SA; Mitkevich VA; Medvedev AE; Ivanov AS; Bodoev NV; Makarov AA; Radko SP
    Mol Biol (Mosk); 2015; 49(3):507-14. PubMed ID: 26107905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping ApoE/Aβ binding regions to guide inhibitor discovery.
    Liu Q; Wu WH; Fang CL; Li RW; Liu P; Lei P; Hu J; Sun X; Zheng YZ; Zhao YF; Li YM
    Mol Biosyst; 2011 May; 7(5):1693-700. PubMed ID: 21409287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
    Parikh ND; Klimov DK
    J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
    Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
    ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.